Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer. It works on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells that inhibit the cancer-fighting humoral immune system.
|Employees (est.) (Feb 2020)||4|
Navrogen total Funding
Navrogen latest funding size
Time since last funding
|5 months ago|
|Ben Franklin Technology Partners of Southeastern Pennsylvania|
When was Navrogen founded?
Navrogen was founded in 2017.
How many employees does Navrogen have?
Navrogen has 4 employees.
Who are Navrogen competitors?
Competitors of Navrogen include Thermosome, Prelude Therapeutics and Apollomics.
Receive alerts for 300+ data fields across thousands of companies